Good Clinical Practice (GCP) and Compliance

Good Clinical Practice (GCP) is a set of internationally recognized ethical and scientific quality requirements that must be observed for designing, conducting, recording, and reporting clinical trials involving human participants. Compliance with these standards provides public assurance that the rights, safety, and well-being of trial subjects are protected, consistent with the principles originating from the Declaration of Helsinki, and that the clinical trial data are credible.
Click to read the full article.

Good Clinical Practice (GCP) is a global quality standard for the planning, conduct, recording, and reporting of clinical trials that involve human subjects. Compliance with GCP principles ensures the rights, safety, and well-being of trial subjects and the credibility of clinical trial data. However, there are common GCP compliance issues that clinical trial sponsors, researchers, and institutions face. This article will discuss these issues and provide guidance on how to avoid them.
Click to read the full article.

In the clinical research industry, adherence to Good Clinical Practice (GCP) is crucial for ensuring ethical, scientific, and quality standards in the design, conduct, recording, and reporting of clinical trials involving human subjects. This is where a GCP audit comes in – it provides an independent review of clinical trial activities to ensure GCP compliance.
Click to read the full article.

The conduct of clinical trials involves multiple key stakeholders, primarily sponsors and investigators, with each having specific responsibilities as outlined in Good Clinical Practice (GCP). Understanding these responsibilities is crucial for the successful execution of a clinical trial and for ensuring GMP compliance. This article provides an overview of the GCP responsibilities of sponsors versus investigators, helping to clarify roles and ensure adherence to Pharma regulatory documentation guidelines.
Click to read the full article.

GCP (Good Clinical Practice) Monitoring Plan is a critical component of clinical research. It plays an essential role in ensuring the integrity of clinical data and the protection of subjects’ rights, safety, and welfare. The plan ensures that the study is conducted, recorded, and reported in accordance with the protocol, Standard Operating Procedures (SOPs), Good Clinical Practice (GCP), and the applicable regulatory requirements. For more details on Pharma SOPs and Pharma SOP documentation, visit Pharma SOPs and Pharma SOP documentation.
Click to read the full article.

The recent surge in remote and hybrid clinical trials has created new challenges in maintaining Good Clinical Practice (GCP). As the clinical trial landscape evolves, it’s crucial for organizations to adapt their strategies to uphold GCP standards. This guide will walk you through the key steps to maintain GCP in remote and hybrid trials, with links to useful resources for further reading.
Click to read the full article.

Good Documentation Practices (GDP) are an integral part of Good Clinical Practices (GCP). They ensure the quality and integrity of the data generated in a clinical study. GDP is not just about writing but also about handling, changing, and maintaining documents. This article will guide you through the best documentation practices to conform with GCP standards.
Click to read the full article.

Good Clinical Practice (GCP) is a set of international ethical and scientific quality standards for designing, conducting, recording, and reporting trials that involve the participation of human subjects. Compliance with these standards provides public assurance that the rights, safety, and well-being of trial subjects are protected and that the data generated are credible and accurate. However, violations of these guidelines have been on the rise, leading to increased regulatory enforcement. This article will discuss the major trends in regulatory enforcement concerning GCP violations.
Click to read the full article.